Studies of LAT mutations in mouse models, where the COOH-terminal tyrosine residues of LAT are altered, have shown that defective LAT signaling can lead to lymphoproliferative disorders characterized by polyclonal T cells with increased Th2 cytokine production (61). The gene discussed is LAT; the disease is lymphoproliferative syndrome.